(1 - 3 von 4
)
Biotech lobbies for flow-through shares | Canadian Lawyer
www.canadianlawyermag.com
Despite the optimism, Stephen Fyfe of Borden Ladner Gervais LLP's Toronto office warns that the success of the flow-through lobby is far from a guarantee.
sortiert nach Relevanz / Datum